Asmaa M. Zahran

Asmaa M. Zahran

Auto-generated profile, based on publicly available information

Asmaa M. Zahran

Clinical Pathology Department, South Egypt Cancer Institute, Assiut University, Assiut, Egypt

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 June 2020 in Vaccines
Verified
Journal Article
Open access
PDF file
Helal HettaHelal Hetta
Helal Hetta
IMIbrahim M. Mwafey
Ibrahim M. Mwafey
Gaber El-Saber BatihaGaber El-Saber Batiha
Gaber El-Saber Batiha
SASULIMAN ALOMAR
SULIMAN ALOMAR
NMNahed A. Mohamed
Nahed A. Mohamed
AZAsmaa M. Zahran
Asmaa M. Zahran
Regulatory B cells (Bregs) are unique subpopulations of B cells with immune-regulating or immune-suppressing properties and play a role in peripheral tolerance. Due to the current limitations of human Breg studies among periodontal diseases, in the present study, we tried to analyze the change in circulating Bregs, pro-inflammatory, and anti-inflammatory cytokines in patients with periodontitis. Peripheral blood from 55 patients with stage 2 periodontitis and 20 healthy controls was analyzed using flow cytometry to evaluate the frequency of CD19+CD24+CD38+ Breg cells. ELISA was used to assess the serum levels of the pro-inflammatory cytokines, including interleukins (IL)-1β, IL-6, TNF-α, and anti-inflammatory cytokines including IL-10, IL-35, and TGF-β. Increased proportions of Breg cells were observed in patients with stage 2 periodontitis compared to controls. Serum levels of cytokines were significantly higher in patients with periodontitis compared to controls. A significant positive correlation was observed between the frequencies of Breg cells and IL35 levels, IL10 levels, and TGF-β. In conclusion, our results suggest that the increase in peripheral Breg cells and serum cytokine levels among periodontitis patients seems to be closely associated with disease progression, a possible link between periodontitis, and systemic inflammatory process.

11 July 2020 in Vaccines
Verified
Journal Article
Open access
PDF file
Helal HettaHelal Hetta
Helal Hetta
MMMohamed Mekky
Mohamed Mekky
AZAsmaa M. Zahran
Asmaa M. Zahran
MAMohamed O. Abdel-Malek
Mohamed O. Abdel-Malek
HRHaidi Karam-Allah Ramadan
Haidi Karam-Allah Ramadan
MEMohamed El-Mokhtar
Mohamed El-Mokhtar
Although regulatory B cells (Bregs) have been proven to play a suppressive role in autoimmune diseases, infections and different tumors, little is known regarding hepatocellular carcinoma (HCC), especially in hepatitis C-related settings. Herein, we analyzed the frequency of circulating Bregs, serum levels of IL-10, IL-35 and B-cell activating factor (BAFF) and investigated their association with regulatory T cells (Tregs) and disease progression in HCV-related HCC. For comparative purposes, four groups were enrolled; chronic HCV (CHC group, n = 35), HCV-related liver cirrhosis (HCV-LC group, n = 35), HCV-related HCC (HCV-HCC group, n = 60) and an apparently healthy control (Control-group, n = 20). HCC diagnosis and staging were in concordance with the Barcelona Clinic Liver Cancer (BCLC) staging system. Analysis of the percentage of Breg cells and peripheral lymphocyte subsets (Treg) was performed by flow cytometry. Serum cytokine levels of IL-10, IL-35 and B-cell activating factor (BAFF) were measured by ELISA. The frequency of Bregs was significantly higher in the HCV-HCC group compared to the other groups and controls. A significant increase was noted in late-HCC versus those in the early stages. The frequency of Bregs was positively correlated with Tregs, serum IL-10, IL-35 and BAFF. In conclusion, Peripheral Bregs were positively correlated with the frequency of Tregs, IL-10, IL-35 and BAFF, and may be associated with HCV-related HCC progression.

11 October 2021 in Journal of Immunology Research
Verified
Journal Article
Open access
PDF file
AZAsmaa M. Zahran
Asmaa M. Zahran
Helal HettaHelal Hetta
Helal Hetta
ZZZeinab Albadry M. Zahran
Zeinab Albadry M. Zahran
ARAlaa Rashad
Alaa Rashad
ARAmal Rayan
Amal Rayan
HNHanaa Nafady-Hego
Hanaa Nafady-Hego
Background and Aim. Myeloid-derived suppressor cells (MDSCs) contribute to the process of malignant transformation and tumor progression through immuno- and nonimmunosuppressive mechanisms. The current study is aimed at providing the predictive and prognostic role of Mo-MDSCs in advanced non-small-cell lung cancer (NSCLC) in relation to different hematologic indices. Methods. We recruited 40 cases of advanced NSCLC, stages III and IV, years old, and eligible to receive chemotherapy with or without radiotherapy, along with 20 healthy controls of comparable age and sex; after diagnosis and staging of patients, blood samples were collected for flow cytometric detection of Mo-MDSCs. Results. Significant accumulation of Mo-MDSCs in patients compared to their controls ( ). Furthermore, these cells accumulated significantly in stage IV compared to stage III ( ) and correlated negatively with overall survival ( , ), lymphocyte to monocyte ratio ( , ), and mean platelet volume to platelet count ratio (MPV/PC) ( , ), patients with had significantly better survival than those with

14 October 2026 in BMC Cancer
Verified
Journal Article
Open access
PDF file
Helal HettaHelal Hetta
Helal Hetta
AZAsmaa M. Zahran
Asmaa M. Zahran
ENEmad Eldin Nabil
Emad Eldin Nabil
AEAzza A Elkady
Azza A Elkady
AGAsmaa M. Goda
Asmaa M. Goda
OAOla A. Alkady
Ola A. Alkady
The role of regulatory B cells (Bregs) cells and regulatory T cells (Tregs) has been little investigated in non-small cell lung cancer (NSCLC). Therefore,